标题
Toll-like Receptors from the Perspective of Cancer Treatment
作者
关键词
-
出版物
Cancers
Volume 12, Issue 2, Pages 297
出版商
MDPI AG
发表日期
2020-01-28
DOI
10.3390/cancers12020297
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
- (2019) Javaid et al. Pharmaceutics
- Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
- (2016) Ronaldo A. Ribeiro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
- (2016) W.-T. Kuo et al. CANCER RESEARCH
- Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4
- (2016) Jean-François Llitjos et al. JOURNAL OF PATHOLOGY
- CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma
- (2016) Hridayesh Prakash et al. Scientific Reports
- TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
- (2016) Thibaud Spinetti et al. OncoImmunology
- Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice
- (2015) Hiroyasu Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
- (2015) TANJA GRIMMIG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer
- (2015) Xiyu Liu et al. TUMOR BIOLOGY
- Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer
- (2015) Yun Luo et al. Oncotarget
- TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
- (2015) Dayson Moreira et al. Oncotarget
- TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small Cell Lung Cancer
- (2014) S. Chatterjee et al. CANCER RESEARCH
- Role of Toll-like receptors in cervical, endometrial and ovarian cancers: A review
- (2014) Nader Husseinzadeh et al. GYNECOLOGIC ONCOLOGY
- High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer
- (2014) Hui Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression
- (2014) Ming Shi et al. PLoS One
- Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
- (2013) V Damiano et al. BRITISH JOURNAL OF CANCER
- TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
- (2013) Ilana Chefetz et al. CELL CYCLE
- TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
- (2013) Hongliang Fang et al. Cellular & Molecular Immunology
- Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer
- (2013) Laure Belmont et al. INTERNATIONAL JOURNAL OF CANCER
- NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
- (2013) Aurélie Couturier-Maillard et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2
- (2013) Chaoguang Xin et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro
- (2013) Dong Li et al. PLoS One
- Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
- (2013) Chung Truong Nguyen et al. VACCINE
- Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production
- (2013) X Yuan et al. Cell Death & Disease
- Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
- (2012) George E. Theodoropoulos et al. BREAST
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
- (2012) Fatih Arslan et al. Circulation-Cardiovascular Interventions
- Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer
- (2012) Albert S. Baldwin IMMUNOLOGICAL REVIEWS
- The application of Toll like receptors for cancer therapy
- (2012) Eui Young So et al. International Journal of Biological Sciences
- Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
- (2012) Huan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
- (2012) Sergei I. Grivennikov et al. NATURE
- Anticancer TLR agonists on the ropes
- (2012) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation
- (2012) J. M. Reynolds et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
- (2012) J. Garaude et al. Science Translational Medicine
- Targeting pattern recognition receptors in cancer immunotherapy
- (2012) Nadège Goutagny et al. Targeted Oncology
- CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production
- (2012) Xiaoli Li et al. TUMOR BIOLOGY
- Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
- (2012) Francesc Rudilla et al. VACCINE
- Synbiotics in Health and Disease
- (2012) Sofia Kolida et al. Annual Review of Food Science and Technology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists
- (2011) P L Triozzi et al. CANCER GENE THERAPY
- Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells
- (2011) Nanae Harashima et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy
- (2011) Jee Youn Kim et al. CANCER LETTERS
- Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
- (2011) Z. Cai et al. CANCER RESEARCH
- LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases 1 Integrin-Mediated Cell Adhesion and Liver Metastasis
- (2011) R. Y. C. Hsu et al. CANCER RESEARCH
- Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
- (2011) M. B. Davis et al. CLINICAL CANCER RESEARCH
- High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4
- (2011) Xiao-Mei Zhu et al. CYTOKINE
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
- (2011) Marko Babjuk et al. EUROPEAN UROLOGY
- Effects of Toll-like receptor signals in T-cell neoplasms
- (2011) Cori Morrison et al. Future Oncology
- Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses
- (2011) Mohamed Labib Salem IMMUNOLOGY LETTERS
- The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C
- (2011) Hans-Dieter Nischalke et al. INTERNATIONAL JOURNAL OF CANCER
- Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
- (2011) Lyudmila G. Burdelya et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
- (2011) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function
- (2010) D. Geng et al. BLOOD
- Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens
- (2010) D. Geng et al. CANCER RESEARCH
- Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
- (2010) Arnold I. Chin et al. CANCER RESEARCH
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis
- (2010) Manabu Taura et al. CANCER SCIENCE
- Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
- (2010) H. Lu et al. CLINICAL CANCER RESEARCH
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
- (2010) Joseph M. Reynolds et al. IMMUNITY
- Mycobacterium tuberculosisLipoproteins Directly Regulate Human Memory CD4+T Cell Activation via Toll-Like Receptors 1 and 2
- (2010) Christina L. Lancioni et al. INFECTION AND IMMUNITY
- TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice
- (2010) José M. González-Navajas et al. JOURNAL OF CLINICAL INVESTIGATION
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Priming of CD8 T Cell Immunity to Herpes Simplex Virus Type 1 Requires Cognate TLR3 Expression In Vivo
- (2010) Gayle M. Davey et al. JOURNAL OF IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bacteria Peptidoglycan Promoted Breast Cancer Cell Invasiveness and Adhesiveness by Targeting Toll-Like Receptor 2 in the Cancer Cells
- (2010) Wenjie Xie et al. PLoS One
- Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
- (2009) W. Elliot Love et al. ARCHIVES OF DERMATOLOGY
- Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells
- (2009) Wenjie Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation
- (2009) D. Piccioli et al. BLOOD
- Toll-like receptor expression in normal ovary and ovarian tumors
- (2009) Mingfu Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats
- (2009) R. K. Le Leu et al. CARCINOGENESIS
- PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis
- (2009) P Wang et al. CELL DEATH AND DIFFERENTIATION
- Direct recognition of LPS by human but not murine CD8+T cellsviaTLR4 complex
- (2009) Mousa Komai‐Koma et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The contribution of direct TLR signaling to T cell responses
- (2009) Adeeb H. Rahman et al. IMMUNOLOGIC RESEARCH
- Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer
- (2009) I. Niedzielska et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
- (2009) S. A. Broomfield et al. JOURNAL OF IMMUNOLOGY
- TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal
- (2009) B. C. Mercier et al. JOURNAL OF IMMUNOLOGY
- Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway
- (2009) Mio Ikebe et al. JOURNAL OF SURGICAL ONCOLOGY
- NF-κB and cancer: how intimate is this relationship
- (2009) Sahdeo Prasad et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell In Vivo
- (2009) Tao Ren et al. PATHOLOGY & ONCOLOGY RESEARCH
- Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
- (2009) Geoffrey W. Stone et al. PLoS One
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
- Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC- -dependent mechanism
- (2008) A. Paone et al. CARCINOGENESIS
- Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
- (2008) Nicole Asprodites et al. FASEB JOURNAL
- Toll‐like receptors and adaptor molecules in liver disease: Update
- (2008) Ekihiro Seki et al. HEPATOLOGY
- Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma
- (2008) Maja A. Hofmann et al. JOURNAL OF IMMUNOTHERAPY
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
- (2008) Brian J Zarnegar et al. NATURE IMMUNOLOGY
- Role of Toll-like receptors in gastrointestinal malignancies
- (2008) M Fukata et al. ONCOGENE
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
- The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice
- (2008) Mohamed L. Salem et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now